Melinda French Gates announced a $215 million commitment to women's health, focusing on menopause and midlife health. Her firm, Pivotal, will support provider education, insurance coverage, and workplace protections, aiming to signal the viability of this sector for investment and philanthropy.
Melinda French Gates has announced a $215 million philanthropic commitment to women's health, with a significant focus on menopause and midlife health. Through her firm Pivotal, which integrates philanthropy, investing, and policy advocacy, she aims to address the under-researched and under-funded aspects of women's health during their peak productivity years. The initiative will support provider education, expanded insurance and Medicaid coverage, and workplace protections, alongside public education campaigns. French Gates highlighted that women often leave the workforce due to menopause symptoms, impacting their career progression and overall power. This investment is intended to signal the viability of women's midlife health as a critical sector for both philanthropy and business, with companies like Midi and Maven already demonstrating commercial opportunities in the estimated $600 billion menopause market. Pivotal's existing portfolio includes companies focused on medically-backed startups in women's health.
This significant investment by a prominent philanthropist aims to elevate women's midlife health from an under-addressed issue to a recognized category for investment and policy change, potentially impacting millions of women's health outcomes and economic participation.